Florbetaben for Imaging of Vascular Amyloid (NCT06091319)
Florbetaben for Imaging of Vascular Amyloid: Evaluation of Amyloid Inflammasome Imaging in Carotid and Coronary Arteries in Patients With Unstable Atherosclerosis- A Pilot Study
🩺 Plain-English Summary (8th-Grade Level)
The Primary Objective is to determine if a new nuclear tracer (named 18F-Florbetaben) used with nuclear imaging (PET imaging) can detect inflamed plaque in patients with recent ACS or stroke/TIA.
Who can join: Review the eligibility criteria below.
Location: University of Ottawa Heart Institute — Ottawa, Ontario
Age range: 18 Years
🧪 Interventions in This Study
- [18F]-Florbetaben PET and CT imaging (PROCEDURE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Ottawa Heart Institute — Ottawa, Ontario
📞 Contact the Study Coordinator
Phone: (613) 282-1835
Email: kboczar@ottawaheart.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Acute Coronary Syndrome
- LEADERS FREE II: BioFreedom™ Pivotal Study — Huntsville, Alabama
- OPTIMIZE Sirolimus-Eluting Coronary Stent Systems Pharmacokinetics (PK) Study — Scottsdale, Arizona
- Post Acute Cardiac Event Smoking (PACES) Study — Minneapolis, Minnesota
- DAPT Strategy in HBR Patients Undergoing Complex PCI Following ACS: Second-Phase Beta Testing of a Patients Decision Aid — Montreal, Quebec
- Tailoring Post Discharge - Remote Education and Access for Cardiac Health — Winnipeg, Manitoba
- A Prospective Research Investigation of Ischemia Using MCG — Rochester, Minnesota
Explore by condition: All Acute Coronary Syndrome clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.